PATENT CLAIM ANALYSIS

Application Number: 16057350
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "249000"]

Abstract:
The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Claim (Index 4):
The method of  claim 1 , wherein the condition is schizophrenia or depression.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14577480', '14883174', '15118447', '15118461', '15334198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8113497101911901
- 35 USC 102 Novelty (BERT): 0.5742195817817429
- Combined Prediction Score: 0.7876366973502453
- Mean Citation Score: 447.3881960000001
- Max Citation Score: 600.1733
- Similarity Product: 322.2382579719365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test